JNJ-61432059 is primarily investigated for its potential therapeutic applications in the field of oncology. It is being studied as an inhibitor targeting specific pathways involved in cancer cell proliferation and survival. Early research suggests it may play a role in disrupting tumor growth by modulating key molecular mechanisms that drive cancer progression. Its application is focused on developing targeted therapies for certain types of cancers, potentially offering a more precise treatment option with fewer side effects compared to conventional chemotherapy. Clinical trials are ongoing to evaluate its efficacy and safety in human patients.